VIR

9.06

0.44% 0.04

Dopo l'orario di chiusura: 9.06

Vir Biotechnology Inc (VIR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché VIR Giù? Forum Previsione

Precedente Chiudi:

$9.02

Aprire:

$8.662

Volume 24 ore:

1.73M

Relative Volume:

0.53

Capitalizzazione di mercato:

$1.45B

Reddito:

$68.56M

Utile/perdita netta:

$-437.99M

Rapporto P/E:

-2.8636

EPS:

-3.1639

Flusso di cassa netto:

$-396.61M

1 W Prestazione:

+1.12%

1M Prestazione:

-3.00%

6M Prestazione:

+60.07%

1 anno Prestazione:

+39.81%

Intervallo 1D:

$8.6501

$9.40

Intervallo di 1 settimana:

$8.26

$9.40

Portata 52W:

$4.155

$10.94

Vir Biotechnology Inc Stock (VIR) Company Profile

Nome

Vir Biotechnology Inc

Settore

Healthcare (1118)

Industria

Biotechnology (624)

Telefono

415-906-4324

Indirizzo

1800 OWENS STREET, SAN FRANCISCO, CA

Dipendente

367

Cinguettio

@Vir_Biotech

Prossima data di guadagno

2024-10-31

Ultimi documenti SEC

VIR's Discussions on Twitter

Compare VIR vs VRTX, REGN, ARGX, ALNY, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VIR Vir Biotechnology Inc	9.06	1.45B	68.56M	-437.99M	-396.61M	-3.1639
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Vir Biotechnology Inc Stock (VIR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-24	Aggiornamento	Raymond James	Outperform → Strong Buy
2025-09-03	Iniziato	Evercore ISI	Outperform
2025-08-27	Aggiornamento	BofA Securities	Neutral → Buy
2024-01-29	Downgrade	JP Morgan	Overweight → Neutral
2023-09-08	Downgrade	BofA Securities	Buy → Neutral
2023-03-06	Aggiornamento	JP Morgan	Neutral → Overweight
2023-02-21	Aggiornamento	Goldman	Neutral → Buy
2023-01-27	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2022-09-14	Iniziato	SVB Leerink	Outperform
2022-09-09	Iniziato	Morgan Stanley	Underweight
2022-03-03	Aggiornamento	Robert W. Baird	Underperform → Neutral
2021-12-21	Downgrade	Robert W. Baird	Neutral → Underperform
2021-10-25	Aggiornamento	JP Morgan	Underweight → Neutral
2021-09-22	Downgrade	Goldman	Buy → Neutral
2021-06-04	Ripresa	Robert W. Baird	Neutral
2021-01-27	Downgrade	JP Morgan	Neutral → Underweight
2021-01-20	Reiterato	H.C. Wainwright	Buy
2020-10-05	Iniziato	BofA Securities	Buy
2020-09-14	Aggiornamento	Goldman	Neutral → Buy
2020-09-11	Aggiornamento	JP Morgan	Underweight → Neutral
2020-08-20	Iniziato	Needham	Buy
2020-03-19	Downgrade	JP Morgan	Neutral → Underweight
2020-03-13	Downgrade	Goldman	Buy → Neutral
2020-02-27	Downgrade	Robert W. Baird	Neutral → Underperform
2020-02-04	Downgrade	JP Morgan	Overweight → Neutral
2019-11-14	Iniziato	Robert W. Baird	Neutral
2019-11-05	Iniziato	Barclays	Overweight
2019-11-05	Iniziato	Cowen	Outperform
2019-11-05	Iniziato	Goldman	Buy
2019-11-05	Iniziato	JP Morgan	Overweight

Mostra tutto

Vir Biotechnology Inc Borsa (VIR) Ultime notizie

Apr 04, 2026

VIR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026

Evercore ISI Group Initiates Coverage of Vir Biotechnology (VIR) with Outperform Recommendation - MSN

Apr 04, 2026

Apr 03, 2026

VIR SEC FilingsVir Biotechnology, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 03, 2026

Apr 02, 2026

Market Catalysts: Is Vir Biotechnology Inc a good stock for dollar cost averaging2026 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn

Apr 02, 2026

Insider Sell: Vicki Sato Sells 22,000 Shares of Vir Biotechnology Inc (VIR) - GuruFocus

Apr 02, 2026

Vir Biotechnology (NASDAQ:VIR) Director Sells $199,540.00 in Stock - MarketBeat

Apr 02, 2026

Vir Biotechnology director Sato sells $199k in shares By Investing.com - Investing.com South Africa

Apr 02, 2026

Vir Biotechnology director Sato sells $199k in shares - Investing.com

Apr 02, 2026

Vir Biotechnology (VIR) director sells 22,000 shares in open market - Stock Titan

Apr 02, 2026

Apr 01, 2026

Vir Biotechnology (VIR) price target increased by 26.10% to 20.74 - MSN

Apr 01, 2026

Mar 30, 2026

Energy Moves: Is Vir Biotechnology Inc stock a smart retirement pickPortfolio Update Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Mar 30, 2026

Bull Bear: Is Vir Biotechnology Inc stock heavily shortedNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn

Mar 30, 2026

Investor Mood: How volatile is LGLWS stockWeekly Earnings Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Why did Vir Biotechnology stock surge 60% after-hours today? - MSN

Mar 29, 2026

Mar 28, 2026